You are here

andexanet alfa

In a comeback, Portola scores FDA accelerated approval for once-rejected Andexxa

Endpoints

Fri, 05/4/18 - 10:13 am

Portola Pharmaceuticals

Two Red Hot Biotechs With Big Near-term Catalysts Ahead

Motley Fool

Mon, 05/29/17 - 12:09 pm

Portola Pharmaceuticals

Cotempla XR-OTD

When Can Portola's Drug Be Approved, And How Much Does It Matter?

Seeking Alpha

Wed, 08/24/16 - 10:51 am

Portola Pharmaceuticals

Portola Approval And Headache Data From Lilly

Seeking Alpha

Sat, 08/13/16 - 02:51 pm

Portola Pharmaceuticals

Why Portola Pharmaceuticals Shares Jumped 82% in 2015

Motley Fool

Thu, 01/7/16 - 08:52 am

Portola Pharmaceuticals

Bristol-Myers Squibb

3 Small-Cap Biotech Stocks With Big News Coming in 2016

Motley Fool

Sat, 12/12/15 - 02:05 pm

Portola Pharmaceuticals

The Small-Cap Biotech Stock You Should Be Watching

Motley Fool

Mon, 02/16/15 - 11:50 am

Portola's drug reverses effect of J&J's blood thinner Xarelto

Yahoo/Reuters

Fri, 01/9/15 - 09:14 am

Portola Pharmaceuticals

Bristol-Myers Squibb and Pfizer Inc.'s Bet on This Small Biotech Stock Could Pay Off

Motley Fool

Mon, 12/1/14 - 09:12 am

Bristol-Myers Squibb

Portola Pharmaceuticals

Portola Pharma drug reverses effect of anti-clotting drugs in study

Yahoo/Reuters

Wed, 10/1/14 - 10:37 am

Portola Pharmaceuticals

Portola Pharmaceuticals begins enrollment in Phase 3 study for Xarelto/andexanet alfa combo

The Fly on the Wall

Mon, 05/12/14 - 09:12 am

Portola Pharmaceuticals

Today’s Top Biotech Stories: Horizon Pharma, Prothena, and Portola Pharmaceuticals

Motley Fool

Wed, 03/19/14 - 12:01 pm

Portola Pharmaceuticals

Portola takes its 'breakthrough' bleeding drug to PhIII with Bayer, J&J in tow

Fierce Biotech

Tue, 02/4/14 - 08:13 am

Portola shoots for early FDA approval after nabbing 'breakthrough' status

Fierce Biotech

Mon, 11/25/13 - 11:57 am

breakthrough therapies